Kolinpharma Statements
KI
Kolinpharma Income Statement
B
M
EUR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
8.32
100
3.672
44.1
4.648
55.9
—
0
2.873
34.5
3.816
45.9
0.832
10
-0.126
-1.5
—
0
0.565
6.8
0.195
2.3
0.369
4.4
0.232
1.589
5.743
100
2.464
42.9
3.279
57.1
—
0
2.582
44.9
3.14
54.7
0.139
2.4
-0.109
-1.9
—
0
0.031
0.5
0.057
1
-0.027
-0.5
-0.016
1.64
6.059
100
2.704
44.6
3.354
55.4
—
0
2.255
37.2
2.829
46.7
0.525
8.7
-0.127
-2.09
—
0
0.354
5.8
0.092
1.5
0.262
4.3
0.16
1.64
5.115
100
1.855
36.3
3.259
63.7
—
0
2.262
44.2
2.586
50.6
0.674
13.2
-0.109
-2.1
—
0
0.564
11
0.189
3.7
0.375
7.3
0.229
1.64
4.783
100
1.117
23.3
3.666
76.7
—
0
1.4
29.3
2.574
53.8
1.093
22.8
-0.087
-1.8
—
0
1.006
21
0.236
4.9
0.77
16.1
0.47
1.64
3.42
100
0.943
27.6
2.477
72.4
—
0
2.137
62.5
2.577
75.3
-0.099
-2.9
-0.02
-0.6
—
0
-0.12
-3.5
0.008
0.2
-0.128
-3.7
-0.078
1.64
4.555
100
0.077
1.7
4.478
98.3
—
0
2.984
65.5
3.505
76.9
0.973
21.4
-0.041
-0.9
—
0
0.932
20.5
0.208
4.6
0.724
15.9
0.442
1.64
4.362
100
1.273
29.2
3.089
70.8
—
0
2.612
59.9
3.196
73.3
-0.107
-2.5
-0.03
-0.7
—
0
-0.137
-3.1
-0.004
-0.09
-0.133
-3.04
-0.081
1.64
3.072
100
3.148
102.5
-0.077
-2.5
—
0
-1.09
-35.5
-0.744
-24.2
0.667
21.7
-0.041
-1.3
—
0
0.626
20.4
0.192
6.2
0.434
14.1
0.265
1.64
4.099
100
1.151
28.1
2.948
71.9
—
0
2.602
63.5
3.066
74.8
-0.118
-2.9
-0.046
-1.1
—
0
-0.163
-4
-0.005
-0.1
-0.159
-3.9
-0.097
1.64
1.985
2.138
-0.153
—
-0.633
-0.349
0.196
-0.04
—
0.156
0.042
0.114
0.114
1
2.078
0.551
1.527
—
1.387
1.692
-0.165
-0.035
—
-0.199
-0.019
-0.18
-0.18
1